These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27792243)

  • 1. Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.
    Zwertbroek EF; Broekhuijsen K; Langenveld J; van Baaren GJ; van den Berg PP; Bremer HA; Ganzevoort W; van Loon AJ; Mol BW; van Pampus MG; Perquin DA; Rijnders RJ; Scheepers HC; Sikkema MJ; Woiski MD; Groen H; Franssen MT;
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):96-105. PubMed ID: 27792243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
    Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
    Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.
    Koopmans CM; van der Tuuk K; Groen H; Doornbos JP; de Graaf IM; van der Salm PC; Porath MM; Kuppens SM; Wijnen EJ; Aardenburg R; van Loon AJ; Akerboom BM; van der Lans PJ; Mol BW; van Pampus MG;
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):399-407. PubMed ID: 24575790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term.
    van der Tuuk K; Koopmans CM; Groen H; Aarnoudse JG; van den Berg PP; van Beek JJ; Copraij FJ; Kleiverda G; Porath M; Rijnders RJ; van der Salm PC; Santema JG; Stigter RH; Mol BW; van Pampus MG;
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):339-46. PubMed ID: 21806572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
    van Baaren GJ; Broekhuijsen K; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp K; Scheepers H; Bremer HA; Rijnders R; van Loon AJ; Perquin D; Sporken J; Papatsonis D; van Huizen ME; Vredevoogd CB; Brons J; Kaplan M; van Kaam AH; Groen H; Porath M; van den Berg PP; Mol B; Franssen M; Langenveld J;
    BJOG; 2017 Feb; 124(3):453-461. PubMed ID: 26969198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization.
    Ackerman CM; Platner MH; Spatz ES; Illuzzi JL; Xu X; Campbell KH; Smith GN; Paidas MJ; Lipkind HS
    Am J Obstet Gynecol; 2019 Jun; 220(6):582.e1-582.e11. PubMed ID: 30742823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of hypertensive disorders in pregnancy with maternal characteristics in early gestation: A single-center cohort study.
    Muto H; Yamamoto R; Ishii K; Kakubari R; Takaoka S; Mabuchi A; Mitsuda N
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):341-5. PubMed ID: 27343312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term.
    Koopmans CM; Zwart JJ; Groen H; Bloemenkamp KW; Mol BW; Van Pampus MG; Van Roosmalen J
    Hypertens Pregnancy; 2011; 30(4):433-46. PubMed ID: 20822426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.
    Ukah UV; Payne B; Lee T; Magee LA; von Dadelszen P;
    Hypertension; 2017 Apr; 69(4):705-711. PubMed ID: 28167685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
    van Baaren GJ; Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvanck BW; van Eijck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski M; Bossuyt PM; Opmeer BC; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():79-85. PubMed ID: 26182836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction model for hypertension in pregnancy in nulliparous women using information obtained at the first antenatal visit.
    Nijdam ME; Janssen KJ; Moons KG; Grobbee DE; van der Post JA; Bots ML; Franx A
    J Hypertens; 2010 Jan; 28(1):119-26. PubMed ID: 19907344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of and risk factors for severe maternal complications associated with hypertensive disorders after 36 weeks' gestation in uncomplicated twin pregnancies: A prospective cohort study.
    Yamamoto R; Ishii K; Muto H; Ota S; Kawaguchi H; Hayashi S; Mitsuda N
    J Obstet Gynaecol Res; 2018 Jul; 44(7):1221-1227. PubMed ID: 29673002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of correlation factors and pregnancy outcomes of hypertensive disorders of pregnancy - a secondary analysis of a random sampling in Beijing, China.
    Zhu YC; Yang HX; Wei YM; Zhu WW; Meng WY; Wang YQ; Shang LX; Cai ZY; Ji LP; Wang YF; Sun Y; Liu JX; Wei L; Sun YF; Zhang XY; Luo TX; Chen HX; Yu LJ
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):751-754. PubMed ID: 27145691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of recurrence of hypertensive disorders of pregnancy between 34 and 37 weeks of gestation: a retrospective cohort study.
    van Oostwaard MF; Langenveld J; Bijloo R; Wong KM; Scholten I; Loix S; Hukkelhoven CW; Vergouwe Y; Papatsonis DN; Mol BW; Ganzevoort W
    BJOG; 2012 Jun; 119(7):840-7. PubMed ID: 22469065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late preterm neonatal morbidity in hypertensive versus normotensive women.
    Fratto VM; Ananth CV; Gyamfi-Bannerman C
    Hypertens Pregnancy; 2016 May; 35(2):242-9. PubMed ID: 26930156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term.
    van der Tuuk K; Tajik P; Koopmans CM; van den Berg PP; Mol BWJ; van Pampus MG; Groen H;
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():360-365. PubMed ID: 28131100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies.
    Gibson KS; Waters TP; Bailit JL
    Am J Obstet Gynecol; 2016 Mar; 214(3):389.e1-389.e12. PubMed ID: 26440691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrence of hypertensive disorders of pregnancy, a population-based cohort study.
    Ebbing C; Rasmussen S; Skjaerven R; Irgens LM
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):243-250. PubMed ID: 27874979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
    Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
    BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.